Managers
Eurazeo, via its Eurazeo PME subsidiary, has signed an exclusivity agreement under which it would invest, as a majority shareholder, alongside Groupe Premium’s current shareholders – Montefiore Investment, Groupe Premium’s management including Olivier Farouz, Laurent and Didier Zerbib, Benoît Jauvert and other key executives, together with independent agent partners.
The transaction would value Groupe Premium at EUR290 million and Eurazeo PME’s investment should be around EUR100 million, depending on the level of reinvestment by current shareholders.
Groupe Premium was founded in 2000 and is France’s leading independent broker for life insurance and retirement savings solutions aimed at the
Currencies Direct, a specialist in digital foreign exchange (FX) and international payment services to high value private clients and SMEs, has completed a GBP165 million dividend recapitalisation.
On-demand fulfilment start-up Cubyn has raised EUR35 million in a funding round led by Eurazeo and Bpifrance Large Venture, with new participation from First Bridge Ventures and Fuse Venture Partners, and follow-on funding from DN Capital, 360 Capital, Bpifrance Smart Cities fund and BNPP Développement.
Cubyn will use its new funding to double its team of 85 to 170+ employees by the end of 2021, and deploy its service internationally, starting with Spain and Portugal launching in April 2021 followed by Italy, UK and Germany. The company will also open a 25,000 sq m automated facility in the Paris area
Private Equity Wire’s PEWlive Healthcare Investing Summit brought together GPs, LPS and other private equity experts to share their insights into the fast-changing healthcare sector.
Humatica, a private equity specialist adviser for portfolio organisational effectiveness, has advised private equity firm Intermediate Capital Group (ICG) on its investment in Lucid Group.
Founded in 2007, Lucid Group is a strategic healthcare communications company committed to advancing patient health outcomes through healthcare communications that improve the way patients and diseases are managed, and medicines are used. Lucid Group’s pioneering approaches have received industry-wide recognition and have consistently led to above industry growth.
With offices in the UK, US and Asia, Lucid now employs around 250 people. Lucid works in partnership with the world’s leading pharmaceutical and biotech organisations
The Rise Fund, the global impact investing platform of alternative investment firm TPG, is to invest USD200 million in Airtel Mobile Commerce BV (AMC BV), a wholly owned subsidiary of Airtel Africa.
AMC BV is currently the holding company for several of Airtel Africa’s mobile money operations; and is now intended to own and operate the mobile money businesses across all of Airtel Africa’s fourteen operating countries.
The Transaction values Airtel Africa’s mobile money business at USD2.65 billion on a cash and debt free basis. The Rise Fund will hold a minority stake in AMC BV upon completion of the
The Riverside Company, a private equity firm focused on the smaller end of the middle market, has signed a definitive agreement with Vista Equity Partners (Vista) to sell ARCOS, a specialist in resource management software for utilities, airlines and other critical infrastructure industries.
The proposed transaction is expected to close in the second quarter of this year, subject to the satisfaction of customary closing conditions.
Since 2005, ARCOS’ technology has helped hundreds of the largest utilities and airlines manage their crews and resources, especially in unplanned scenarios where resources are needed on short notice.
“We are proud of the work
Oncology data and informatics platform M2GEN has secured a significant new investment by Clayton, Dubilier & Rice (CD&R) funds, the Merck Global Health Innovation Fund (Merck GHI), and McKesson Ventures. The financial terms of the transaction have not been disclosed.
Merck GHI and McKesson Ventures invested alongside CD&R funds, collectively now the company’s largest shareholder. Existing shareholders Moffitt Cancer Center, Hearst Healthcare, and The Ohio State University Foundation continue to hold a significant minority interest M2GEN. Proceeds from the transaction are expected to accelerate growth of M2GEN’s consented, linked clinical and genomic data asset and advance the technology and informatics
New State Capital Partners (New State) and its portfolio company, Mako Steel, have made a majority investment in Rabco Enterprises LLC, a full-service provider of self-storage building systems based in Winter Garden, Florida.
Together, Mako and Rabco will form a nationwide self-storage solutions company. Terms of the transaction have not been disclosed.
The Rabco executive team will retain a stake in the combined operation. Mako Steel CEO Caesar Wright will become CEO of the combined entity, and Emmett Buster Owens III, president of Rabco, will continue with the combined company. Ron Raboud and Larry Cox, owners of Rabco, will
Resurgens Technology Partners, a software-focused private equity firm, has made a strategic investment in Pennsylvania-based EnergyCAP, Inc.
EnergyCAP’s solution, which includes its industry-leading software and complementary services, is used by more than 2,100 organisations across government, education and commercial sectors to streamline utility bill accounting and energy management.
For decades, EnergyCAP has empowered organisations to derive value from their energy information. The company’s award-winning EnergyCAP software is at the core of each implementation and delivers the functionality that energy, sustainability and facility managers need to meet energy conservation goals, improve their organisation’s bottom line and protect the environment. A market
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
